Buffered Versus Conventional Local Anesthesia for Pain and Anxiety Reduction in School-Aged Children With Pulpitis

ConditionPulpitis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-12
SponsorUniversidad Autonoma de San Luis Potosí

About this trial

The objective of this clinical trial is to evaluate whether buffered local anesthesia is more effective than conventional local anesthesia in reducing pain responses in school-aged children requiring dental treatment for pulpitis. The study will also assess differences in physiological and self-reported indicators of pain and anxiety, as well as anesthetic onset and duration.

The main questions it aims to answer are:

Does buffered local anesthesia reduce behavioral pain scores measured by the FLACC scale compared to conventional local anesthesia? Does buffered local anesthesia improve physiological and psychometric indicators of pain and anxiety during dental procedures?

Methodology: The researchers will compare buffered local anesthesia with conventional local anesthesia during routine dental treatment procedures such as pulpotomy or pulpectomy in primary molars.

Participants will:

Receive either buffered or conventional local anesthesia during dental treatment Undergo pulpotomy or pulpectomy depending on clinical diagnosis Be monitored for pain and anxiety using FLACC scale, heart rate, skin conductance, and Wong-Baker Faces Pain Scale at different stages of treatment Have the onset and duration of anesthesia recorded during and after the procedure Be followed until recovery of soft tissue sensation after treatment

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Children aged 6 to 12 years

Diagnosis of irreversible pulpitis due to dental caries in primary maxillary molars

American Society of Anesthesiologists (ASA) Physical Status Classification I

Cooperative or definitely cooperative behavior according to Frankl Behavioral Scale (Frankl III or IV)

Disqualifiers

Known allergy to any component of local anesthetic solution

History of negative or traumatic dental experiences within the previous 12 months that may interfere with behavioral assessment

Radiographic evidence of periapical pathology associated with the affected tooth

Presence of localized abscess or acute spreading infection at the injection site

Trial design

Design model

Parallel

Treatments tested in this trial

  • Buffered Lidocaine with Epinephrine

    Drug

    Local anesthetic solution buffered with sodium bicarbonate prior to administration in order to increase pH and potentially improve onset and patient comfort during dental procedures.

  • idocaine with Epinephrine (Conventional)

    Drug

    Standard commercially available local anesthetic solution used in routine dental practice without pH modification

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Buffered Local AnesthesiaExperimental treatment 1 intervention
Group B: Conventional Local AnesthesiaActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

FLACC PAIN SCORE

Pain behavior will be assessed using the FLACC(Face, Legs, Activity, Cry, and Consolability) Scale score, during different phases of dental treatment in children with pulpitis receiving local anesthesia. The scale ranges from 0 to 10 points, where 0 indicates no pain and 10 indicates severe pain. Higher scores indicate greater pain intensity and a worse outcome.

Time frame
Baseline (before local anesthetic administration), during anesthetic injection, cavity access (pulpotomy/pulpectomy), and final restoration phase (immediately during procedure)

Secondary outcomes

1

Physiological indicators (Heart Rate)

Description: Heart rate will be recorded using a blood volume pulse (BVP) sensor during dental treatment. Unit of Measure: Beats per minute (bpm)

Time frame
Baseline, during anesthetic injection, cavity access (pulpotomy/pulpectomy), and final restoration phase (immediately during procedure)
2

Physiological indicators (Skin Conductance)

Description: Skin conductance will be measured using electrodermal activity (EDA) sensors during dental treatment. Unit of Measure: MicroSiemens (µS)

Time frame
Baseline, during anesthetic injection, cavity access (pulpotomy/pulpectomy), and final restoration phase (immediately during procedure)
3

Wong-Baker Faces Pain Rating Scale Score

Self-reported pain whit Wong-Baker Faces Pain Rating Scale will be recorded at predefined clinical stages of treatment. Scale ranges from 0 to 10 points, where 0 indicates no pain and 10 indicates the worst pain possible

Time frame
Baseline (before local anesthetic administration, during anesthetic injection, cavity access (pulpotomy/pulpectomy), and final restoration phase (immediately during procedure)
4

Onset of local anesthesia

Description: Time elapsed from completion of local anesthetic injection until confirmation of pulpal anesthesia. Pulpal anesthesia will be verified using cold testing (Endo Ice) after confirmation of soft tissue anesthesia. Unit of Measure: Minutes and seconds

Time frame
From completion of anesthetic injection until confirmation of pulpal anesthesia during the treatment visit.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.